Guns Emma S, Cowell Simon P
Department of Surgery, University of British Columbia, Canada.
Nat Clin Pract Urol. 2005 Jan;2(1):38-43. doi: 10.1038/ncpuro0073.
For almost a decade researchers in the field of urology have investigated lycopene and the chemopreventive potential of the tomato. A potent antioxidant found in abundance in the tomato, lycopene has repeatedly been correlated with reduced risk of prostate cancer in numerous epidemiological and population-based studies. Researchers and clinicians continue to investigate beyond the potent antioxidant properties of lycopene for other mechanisms of action and chemotherapeutic potential. This review examines the preclinical and preliminary clinical evidence surrounding the tomato and the health claims based on lycopene. We have explored recent mechanistic insights and conclude that more clinical research is warranted. The scope and extent of scientific evidence accrued on lycopene and tomato extracts, reported molecular mechanisms of action, and its potential impact on the incidence and severity of prostate cancer are discussed.
近十年来,泌尿外科领域的研究人员一直在研究番茄红素以及番茄的化学预防潜力。番茄红素是番茄中大量存在的一种强效抗氧化剂,在众多流行病学和基于人群的研究中,它一再与降低前列腺癌风险相关联。研究人员和临床医生继续深入研究番茄红素的强大抗氧化特性之外的其他作用机制和化疗潜力。本综述考察了围绕番茄以及基于番茄红素的健康宣称的临床前和初步临床证据。我们探究了近期的机制见解,并得出结论认为有必要进行更多的临床研究。文中讨论了关于番茄红素和番茄提取物积累的科学证据的范围和程度、已报道的分子作用机制及其对前列腺癌发病率和严重程度的潜在影响。